NCT00003291View on ClinicalTrials.gov

Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

March 31, 2006

Conditions
Leukemia
Interventions
GENETIC

cytogenetic analysis

GENETIC

mutation analysis

OTHER

laboratory biomarker analysis

Trial Locations (1)

6001

Princess Margaret Hospital for Children, Perth

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00003291 - Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter